Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) Butanoic Acid
2. K 13675
3. K-13675
4. K-13675-d11
5. K-13675-d7
6. K13675
1. 848259-27-8
2. Pemafibrate [inn]
3. (r)-k-13675
4. K-13675, (r)-
5. (r)-2-(3-((benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic Acid
6. Chembl247951
7. Cas#848259-27-8
8. 17vgg92r23
9. Pemafibrate (jan)
10. Pemafibrate [jan]
11. (2r)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic Acid
12. (2~{r})-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic Acid
13. Unii-17vgg92r23
14. Parmodia (tn)
15. P7f
16. Pemafibrate [mi]
17. K-877
18. (r)-k 13675
19. Pemafibrate [who-dd]
20. Schembl2766188
21. Dtxsid00233891
22. Glxc-25532
23. Bcp20864
24. Ex-a1919
25. Yib25927
26. Bdbm50214899
27. Cs-6084
28. Db15212
29. Ac-36249
30. Hy-17618
31. D10711
32. A914970
33. (r)-k-13675(r)-k-13675
34. Q27251943
35. K-877; (r)-k 13675; Cs-2768
36. K-877; K877; K 877; (r)-k 13675; (r)-k13675; (r)k-13675
37. (r)-2-(3-((n-(benzoxazol-2-yl)-n-(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic Acid
38. (r)-2-[3-[n-(benzoxazol-2-yl)-n-(3-(4-methoxyphenoxy)propyl)aminomethyl]phenoxy]butyric Acid
Molecular Weight | 490.5 g/mol |
---|---|
Molecular Formula | C28H30N2O6 |
XLogP3 | 6.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 13 |
Exact Mass | 490.21038668 g/mol |
Monoisotopic Mass | 490.21038668 g/mol |
Topological Polar Surface Area | 94.3 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 658 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Prevention of cardiovascular events in patients with elevated triglycerides levels, Treatment of hypertriglyceridaemia
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
About the Company : Fujian South Pharmaceutical Co., Ltd. (Southern Pharmaceutical) was established in September 2001 and is located in Mingxi County, Fujian Province. After 16 years of development, ...
About the Company : Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its ex...
About the Company : Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan pr...
Regulatory Info :
Registration Country : Egypt
Brand Name : Pemfibra
Dosage Form : Film Coated Tablet
Dosage Strength : 0.1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Regulatory Info :
Registration Country : Egypt
Brand Name : Pemfibra
Dosage Form : Film Coated Tablet
Dosage Strength : 0.1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 0.1MG
Brand Name : Pemfibra
Approval Date :
Application Number :
Registration Country : Egypt
Market Place
Reply
03 Jan 2025
Reply
12 Oct 2023
Reply
05 Oct 2021
Reply
13 Aug 2020
Reply
07 Feb 2022
ABOUT THIS PAGE
A Pemafibrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pemafibrate, including repackagers and relabelers. The FDA regulates Pemafibrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pemafibrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pemafibrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pemafibrate supplier is an individual or a company that provides Pemafibrate active pharmaceutical ingredient (API) or Pemafibrate finished formulations upon request. The Pemafibrate suppliers may include Pemafibrate API manufacturers, exporters, distributors and traders.
click here to find a list of Pemafibrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pemafibrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pemafibrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pemafibrate GMP manufacturer or Pemafibrate GMP API supplier for your needs.
A Pemafibrate CoA (Certificate of Analysis) is a formal document that attests to Pemafibrate's compliance with Pemafibrate specifications and serves as a tool for batch-level quality control.
Pemafibrate CoA mostly includes findings from lab analyses of a specific batch. For each Pemafibrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pemafibrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pemafibrate EP), Pemafibrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pemafibrate USP).
LOOKING FOR A SUPPLIER?